ATE109792T1 - Bereicherung und konzentrierung von proteinen durch ultrafiltration. - Google Patents

Bereicherung und konzentrierung von proteinen durch ultrafiltration.

Info

Publication number
ATE109792T1
ATE109792T1 AT89118796T AT89118796T ATE109792T1 AT E109792 T1 ATE109792 T1 AT E109792T1 AT 89118796 T AT89118796 T AT 89118796T AT 89118796 T AT89118796 T AT 89118796T AT E109792 T1 ATE109792 T1 AT E109792T1
Authority
AT
Austria
Prior art keywords
ultrafiltration
enrichment
concentration
proteins
whey
Prior art date
Application number
AT89118796T
Other languages
English (en)
Inventor
Christopher Thurman Cordle
Ronald Lewis Thomas
Larry Grant Criswell
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Application granted granted Critical
Publication of ATE109792T1 publication Critical patent/ATE109792T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/34Extraction; Separation; Purification by filtration, ultrafiltration or reverse osmosis
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/14Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/142Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration
    • A23C9/1425Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by dialysis, reverse osmosis or ultrafiltration by ultrafiltration, microfiltration or diafiltration of whey, e.g. treatment of the UF permeate

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Water Supply & Treatment (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Peptides Or Proteins (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT89118796T 1988-10-12 1989-10-10 Bereicherung und konzentrierung von proteinen durch ultrafiltration. ATE109792T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/256,813 US4897465A (en) 1988-10-12 1988-10-12 Enrichment and concentration of proteins by ultrafiltration

Publications (1)

Publication Number Publication Date
ATE109792T1 true ATE109792T1 (de) 1994-08-15

Family

ID=22973692

Family Applications (1)

Application Number Title Priority Date Filing Date
AT89118796T ATE109792T1 (de) 1988-10-12 1989-10-10 Bereicherung und konzentrierung von proteinen durch ultrafiltration.

Country Status (13)

Country Link
US (1) US4897465A (de)
EP (1) EP0363896B1 (de)
JP (1) JPH02218691A (de)
KR (1) KR900005998A (de)
AT (1) ATE109792T1 (de)
AU (1) AU624633B2 (de)
CA (1) CA1330050C (de)
DE (1) DE68917407T2 (de)
ES (1) ES2061873T3 (de)
IE (1) IE64919B1 (de)
IL (1) IL91781A (de)
MX (1) MX163729B (de)
NZ (1) NZ230993A (de)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8729031D0 (en) * 1987-12-11 1988-01-27 Express Foods Group Ltd Isolation of immunoglobulin rich fraction from whey
US5030720A (en) * 1988-09-01 1991-07-09 Merck & Co., Inc. Pres2+S hepatitis B vaccine derived from plasma
US5130237A (en) * 1989-06-19 1992-07-14 Clemson University Substrate conversion with an enzyme immobilized on an ultrafiltration membrane
DE4026365A1 (de) * 1990-08-21 1992-02-27 Biotest Pharma Gmbh Sterilfiltrierte kolostralmilch
IE914558A1 (en) * 1991-02-28 1992-09-09 Abbott Lab Isolation of proteins by ultrafiltration
US5270450A (en) * 1991-02-28 1993-12-14 Abbott Laboratories Soy protein isolates
CH687055A5 (de) * 1993-12-03 1996-09-13 Bucher Guyer Ag Masch Verfahren und Vorrichtung zum Eindicken von Fest/Fluessig-Gemischen mittels Membrantechnologie.
US5310877A (en) * 1993-04-08 1994-05-10 E. I. Du Pont De Nemours And Company Method for separating serum albumin and gamma globulin
US5344565A (en) * 1993-07-26 1994-09-06 Pall Corporation Method of treating a clogged porous medium
NL9301653A (nl) * 1993-09-24 1995-04-18 X Flow Bv Werkwijze voor het verwijderen van troebelheid veroorzakende bestanddelen uit een vloeistof met behulp van microfiltratie.
US5468844A (en) * 1994-01-07 1995-11-21 Protose Technologies Inc. Process for the membrane-filtering of protein solutions
US5707678A (en) * 1995-04-12 1998-01-13 Galagen Inc. Method for microfiltration of milk or colostral whey
US5654025A (en) * 1995-10-30 1997-08-05 Raghunath; Bala Ultrafiltration of cooled milk
US6268487B1 (en) 1996-05-13 2001-07-31 Genzyme Transgenics Corporation Purification of biologically active peptides from milk
CA2197515A1 (en) * 1996-07-15 1998-01-16 Reyad Mahmoud Methods of treating milk products
ATE346676T1 (de) 1996-09-06 2006-12-15 Pall Corp Scherkraft trennverfahren und vorrichtung
AU7701398A (en) 1997-05-30 1998-12-30 Bion, Inc. Large-scale isolation and purification of hif
TW409035B (en) 1997-06-04 2000-10-21 Gist Brocades Bv Starch-based enzyme granulates
US6068993A (en) * 1997-07-02 2000-05-30 Biobras Sa Vector for expression of heterologous protein and methods for extracting recombinant protein and for purifying isolated recombinant insulin
AU3709199A (en) 1998-04-14 1999-11-01 Dsm N.V. Membrane filtration
US6313273B1 (en) * 1999-08-25 2001-11-06 Abbott Laboratories Soy proteins and methods for their production
WO2001085192A1 (en) * 2000-05-05 2001-11-15 Gtc Biotherapeutics, Inc. Transgenically produced decorin
US20040219281A1 (en) * 2000-11-21 2004-11-04 Cargill, Incorporated Modified oilseed material
MXPA03004478A (es) 2000-11-21 2004-10-15 Cargill Inc Material de semillas oleginosas modificado.
US7429399B2 (en) * 2001-06-18 2008-09-30 Solae, Llc Modified oilseed material
US6630195B1 (en) 2000-11-21 2003-10-07 Cargill, Incorporated Process for producing oilseed protein products
US6875459B2 (en) * 2001-09-10 2005-04-05 Henry B. Kopf Method and apparatus for separation of milk, colostrum, and whey
US20040033228A1 (en) 2002-08-16 2004-02-19 Hans-Juergen Krause Formulation of human antibodies for treating TNF-alpha associated disorders
MY150740A (en) * 2002-10-24 2014-02-28 Abbvie Biotechnology Ltd Low dose methods for treating disorders in which tnf? activity is detrimental
BR0316643A (pt) * 2002-11-27 2005-10-11 Gtc Biotherapeutics Inc Anticorpos modificados estavelmente produzidos no leite e método de produzir os mesmos
US7354616B2 (en) * 2003-11-25 2008-04-08 Solae, Llc Modified oilseed material with a high gel strength
US7282571B2 (en) * 2004-02-03 2007-10-16 Cytoskeleton Inc. Methods for stabilizing proteins
US20050220978A1 (en) * 2004-03-31 2005-10-06 Cargill, Incorporated Dispersible protein composition
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
US20080019905A9 (en) * 2005-02-18 2008-01-24 Strome Scott E Method of using an anti-CD137 antibody as an agent for radioimmunotherapy or radioimmunodetection
JP5328019B2 (ja) * 2005-10-21 2013-10-30 レヴォ バイオロジクス インコーポレイテッド 抗体依存性細胞障害活性を増強させた抗体、その調製法および使用法
MX2009010361A (es) 2007-03-29 2009-10-16 Abbott Lab Anticuerpos il-12 anti-humanos cristalinos.
EP2279003A4 (de) * 2008-05-01 2013-04-03 Gtc Biotherapeutics Inc Anti-cd137-antikörper als mittel zur behandlung von entzündlichen erkrankungen
AU2009319856A1 (en) * 2008-11-28 2010-06-03 Abbvie Inc. Stable antibody compositions and methods for stabilizing same
BRPI1012082B1 (pt) 2009-05-27 2022-08-16 Takeda Pharmaceutical Company Limited Método para preparar uma composição de igg concentrada a partir de plasma
US8993294B2 (en) 2009-08-10 2015-03-31 Danisco Us Inc. Cross-flow membrane filtration-based process for protein recovery
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
CA2872907A1 (en) 2012-05-09 2013-11-14 The University Of Akron Enzyme-based protein separation and enrichment from soy meal, wheat meal, and other protein-rich materials derived from plant seeds, fruits and other biomass
NZ704190A (en) 2012-08-22 2018-04-27 Kraft Foods Group Brands Llc Processed cheese with cultured dairy components and method of manufacturing
EP3636657A1 (de) * 2018-10-08 2020-04-15 Ablynx N.V. Chromatographiefreies antikörperreinigungsverfahren
WO2022148549A1 (en) 2020-01-14 2022-07-14 Babylat Gmbh Apparatus and method for obtaining protein-enriched fractions from breast milk
CN116422145A (zh) * 2023-04-18 2023-07-14 江苏洁维生物设备股份有限公司 陶瓷膜超滤系统和超滤方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3431201A (en) * 1967-08-29 1969-03-04 Atomic Energy Commission Hyperfiltration process having ion exchange pretreatment
US3977967A (en) * 1973-05-10 1976-08-31 Union Carbide Corporation Ultrafiltration apparatus and process for the treatment of liquids
NL7603369A (en) * 1976-03-31 1977-10-04 Stichting Bedrijven Van Het Selective removal of inorganic ions from aq. protein concentrates - by ultrafiltration and diafiltration at controlled pH
FR2459619B1 (fr) * 1979-06-26 1983-07-29 Agronomique Inst Nat Rech Procede pour l'obtention a partir de lactoserum, d'un produit enrichi en alpha-lactalbumine et applications dudit procede
DE3432718C1 (de) * 1984-09-06 1986-05-22 Biotest Pharma GmbH, 6000 Frankfurt Verfahren zur Herstellung einer Loesung von Milch- und/oder Kolostralimmunglobulinen
FR2605322B1 (fr) * 1986-10-20 1989-04-28 Applic Tech Nles Procede de separation de certaines proteines du lactoserum ou du lait.

Also Published As

Publication number Publication date
DE68917407D1 (de) 1994-09-15
ES2061873T3 (es) 1994-12-16
IE64919B1 (en) 1995-09-20
NZ230993A (en) 1991-11-26
EP0363896A3 (de) 1991-08-14
DE68917407T2 (de) 1995-02-02
US4897465A (en) 1990-01-30
CA1330050C (en) 1994-06-07
JPH02218691A (ja) 1990-08-31
IE893057L (en) 1990-04-12
KR900005998A (ko) 1990-05-07
IL91781A0 (en) 1990-06-10
MX163729B (es) 1992-06-17
IL91781A (en) 1994-06-24
EP0363896A2 (de) 1990-04-18
AU624633B2 (en) 1992-06-18
AU4257089A (en) 1990-04-26
EP0363896B1 (de) 1994-08-10

Similar Documents

Publication Publication Date Title
ATE109792T1 (de) Bereicherung und konzentrierung von proteinen durch ultrafiltration.
DK38892D0 (da) Proteinpraeparat, monoklonalt antistof fremstillet dermed, fremgangsmaade og middel til detektering, dna-sekvens og extrachromosomalt element indeholdende en saadan dna-sekvens
AU4159185A (en) Method of inhibiting binding of von willebrand factor to human platelets and inducing interaction of platelets with vessel walls
FI854187L (fi) Immunoanalyser foer denaturerade proteinanalyser, saerskilt hb alc, samt antikroppar anvaendbara i dessa.
DK0733069T3 (da) Oprensede Primat CTLA-8-antigener og beslægtede reagenser
NZ224057A (en) A polypeptide of a vascular anticoagulant protein and method of preparation
ATE68826T1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
DK0383234T3 (da) Pasteuriseret, renset von Willebrand-faktor-koncentrat og fremgangsmåde til dets fremstilling
SE8602877L (sv) Extraktionsforfarande for mjolkproteiner, produkter, anvendning av forfarandet och farmaceutiska kompositioner
ATE84193T1 (de) Isolierung einer immunoglobulinreichen molkefraktion.
EP0194578A3 (en) Proteins immobilised on polyamides or cellulose hydrate and the use thereof for the preparation of biocatalysts, test strips or chromatography materials
EP0299741A3 (de) Verfahren und Vorrichtung zur Sequenzierung von Proteinen oder Peptiden
FR2660757B1 (fr) Procede d'identification ou de dosage de proteines et applications.
DE3881023D1 (de) Proteine, expressionsvektoren, die fuer solche proteine kodierende dna enthalten und zellen, die solche expressionsvektoren enthalten.
DE3854550D1 (de) HIV-Peptide und Methoden für den Nachweis von HIV.
ATE50458T1 (de) Bestimmung von fibrin mit fibrin-spezifischen antikoerpern.
DE3273606D1 (en) Process for the purification or concentration of biologically active proteins, and appropriate means therefor
ATE82471T1 (de) Verfahren zur abtrennung bestimmter proteine aus molke.
DK0457035T3 (da) Fremgangsmåde til inaktivering af den biologiske aktivitet af DNA
DE68917520D1 (de) Verfahren und Systeme zur Herstellung von HIV-Antigenen.
DE3783425D1 (de) Mikroorganismen, die fremdproteinenthaltende pili tragen, isolierte pili, verfahren zur ausscheidung von proteinen in verwendung dieser pili und deren nutzen.
DE3853315D1 (de) Verfahren zur quantitativen Bestimmung von Serumproteinen in Körperflüssigkeiten und Mittel zur Durchführung des Verfahrens.
IT8421612A0 (it) Vettore clonante, procedimento per la sua costruzione e procedimentodi concentrazione e di purificazione di proteine prodotte, formate dal vettore clonante.
ATE60247T1 (de) Modifizierte anorganische filtermembran zur proteintrennung.
SE8305667D0 (sv) Adenocarcinoma related new antigenic determinants and antibodies specific thereto, processes for their preparation and reagent systems pertaining to them

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee